Malaria vaccine clears hurdles

Thursday 09 January 1997 00:02 GMT

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The first ever experimental vaccine against malaria to provide a high degree of protection has been identified by scientists at SmithKline Beecham and the Walter Reed Army Institute of Research. In trials, six out of seven volunteers given the most advanced form of the vaccine remained free of infection. All of the non-vaccinated volunteers became infected.

The results described in the New England Journal of Medicine follow 20 years of research in the field looking for replacements for current drugs and scientists will now trial the vaccine in West Africa.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Stay up to date with notifications from The Independent

Thank you for registering

Malaria vaccine clears hurdles

Join our commenting forum

Thank you for registering